A modified anticancer drug can simultaneously target tumor sites and show whether or not it is working
Cancer drugs can be modified to specifically target tumor sites to help personalize cancer treatment. And while it is relatively easy to determine if the drugs have been delivered to the correct location, it is more difficult to monitor their therapeutic success. Now, a team led by Bin Liu from the A*A*STAR Institute of Materials Research and Engineering in Singapore, in collaboration with Ben Zhong Tang at Hong Kong University of Science and Technology, has developed an anticancer drug with an inbuilt mechanism that shows if it is working1.
Platinum-based drugs are effective against many cancers, killing cells by triggering cellular suicide, or apoptosis. These drugs can, however, have severe side effects. Nontoxic forms can be modified, as a type of prodrug, to convert to their toxic form only after entering the targeted tumor cells, so as not to harm noncancerous cells.
Liu and colleagues went one step further by modifying a platinum-based prodrug to not only target tumor cells effectively, but also show whether or not it was having the desired effect. According to Liu, this added feature could be crucial for improving cancer treatment.
“Early evaluation of a patient’s response to a specific cancer therapy is important in clinical applications because it can minimize the duration of ineffective courses,” explains Liu. “The effectiveness of cancer treatment is commonly evaluated using magnetic resonance imaging to measure the tumor size, but this is unsatisfactory as the change in size is not obvious at the early stages of therapy.”
In their new system, Liu and her team included an apoptosis sensor that is released when the prodrug converts to its toxic form inside the targeted tumor cells. The toxic form triggers cell apoptosis and activates an enzyme called caspase 3, which then cleaves the apoptosis sensor and causes it to fluoresce green. This provides a visual signal that the drug is killing the cells.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Anticancer Drug Demonstrates Activity Against SARS-CoV-2, Including B.1.1.7 Variant in the Labon January 28, 2021 at 1:10 am
In laboratory experiments, plitidepsin, a drug approved for the treatment of multiple myeloma, was 27.5-fold more potent against SARS-CoV-2 than remdesivir. In a seperate preprint, researchers show ...
- COVID SCIENCE-Drugs, vaccines less effective vs new virus variants; antibody cocktail may protect patients' contactson January 27, 2021 at 5:20 pm
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
- Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer'son January 27, 2021 at 3:45 pm
The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to ...
- Scientists receive $4.6M grant to study FDA-approved drug for Alzheimer’s Diseaseon January 27, 2021 at 2:15 pm
The National Institute of Aging and the Alzheimer’s Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo ...
- Chemotherapy-induced Nausea and Vomiting Drugs Market Share Current and Future Industry Trends, 2020-2025on January 27, 2021 at 5:33 am
The global Chemotherapy-induced Nausea and Vomiting Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to ...
- Anti-cancer drug discovery made easier with gold nanostructureson January 27, 2021 at 2:22 am
Scientists design a novel 3D cell culture-based electrical platform for high-throughput anti-cancer drug testing using a new type of gold nanostructure.
- Finding a way to stop chemotherapy from damaging the hearton January 26, 2021 at 5:30 pm
COLUMBUS, Ohio - There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests. Scientists found that this chemo ...
- More Defense Against COVID– Anti-Cancer Drug Could Possibly Treat COVID-19on January 26, 2021 at 5:13 pm
Image: Shutterstock.com A University of California-San Francisco science team says it's nearly 30 times more effective than drugs currently used to treat the virus.
- A Promising Way To Find New Anticancer Drugson January 26, 2021 at 2:57 am
Enzymes known as histone deacetylases are targets for a handful of anticancer drugs due to their ability to affect gene expression. Now, researchers have developed a new method to investigate how ...
- New method can help identify potential anti-cancer drugs at a high paceon January 25, 2021 at 2:58 pm
The enzymes in human cells known as histone deacetylases, or HDACs, are targets for a handful of anticancer drugs because of their ability to affect gene expression.
via Bing News